Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study GroupSamantha Mayo, Katherine B. Peters, James D’Olimpio et al.|Supportive Care in Cancer|2020Cited by 144
Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overviewAlexandre Chan, Maryam B. Lustberg, Daniel L. Hertz et al.|Supportive Care in Cancer|2019Cited by 79
The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairmentCourtney B. Subramaniam, Hannah R. Wardill, Joanne M. Bowen et al.|Neuroscience & Biobehavioral Reviews|2020Cited by 55
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseasesJustine M. Kahn, Steven Z. Pavletic, Ruta Brazauskas et al.|Blood Advances|2020Cited by 32
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S. Bhatt, Betty K. Hamilton, Ruta Brazauskas et al.|Transplantation and Cellular Therapy|2021Cited by 25